Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Sirtinol
35
CHF
CHF 35.00
In stock
AG-CR1-0055-M0011 mgCHF 35.00
AG-CR1-0055-M0055 mgCHF 70.00
AG-CR1-0055-M02525 mgCHF 210.00
Product Details | |
---|---|
Synonyms | Sir Two Inhibitor Naphthol; 2-[(2-Hydroxynaphthalen-1-yl-methylene)amino]-N-(1-phenethyl)benzamide |
Product Type | Chemical |
Properties | |
Formula |
C26H22N2O2 |
MW | 394.5 |
CAS | 410536-97-9 |
Purity Chemicals | ≥98% (NMR) |
Appearance | Off-white to yellow solid. |
Solubility | Soluble in DMSO, 100% ethanol or dimethyl formamide. |
Other Product Data |
Relatively unstable in aqueous solution, especially at acidic pH. |
InChi Key | UXJFDYIHRJGPFS-WPWMEQJKSA-N |
Smiles | CC(NC(=O)C1=C(C=CC=C1)\N=C\C1=C(O)C=CC2=C1C=CC=C2)C1=CC=CC=C1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Specific cell permeable SIRT1 (sirtuin 1) inhibitor [1, 2].
- Senescence-like growth arrest inducer [3].
- Platelet aggregation inhibitor [4].
- Apoptosis inducer [5].
Product References
- Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening: C.M. Grozinger, et al.; J. Biol. Chem. 276, 38837 (2001)
- Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors: A. Mai, et al.; J. Med. Chem. 48, 7789 (2005)
- Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells: H. Ota, et al.; Oncogene 25, 176 (2006)
- A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase: F.C. Liu, et al.; Biochem. Pharmacol. 77, 1364 (2009)
- SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2: B. Peck, et al.; Mol. Cancer Ther. 9, 844 (2010)